Candida Infections of Medical Devices
By E. Kojic, R. Darouiche. Clinical Microbiology Reviews, 2004
1,091 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Infectious Diseases, Microbiology
View Paper: https://www.semanticscholar.org/paper/7d95e69de674b04f05a2eaf717bfab943ff7ae35
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Infectious Diseases
In Microbiology
Citations in the corpus
- A Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicans (2012, methodology): “Because biofilm-based catheter infections are a major clinical problem (Kojic and Darouiche, 2004), we used a well-established rat venous catheter model of infection (Andes et al., 2004) to test the six mutants for biofilm formation in vivo.”
- GENETIC CONTROL OF CANDIDA ALBICANS BIOFILM DEVELOPMENT (2010, neutral): “The use of these devices — such as venous catheters, urinary catheters and artificial joints — is now routine, with more than 10 million recipients per yea”
- Flocculation, adhesion and biofilm formation in yeasts (2006, background): “Pathogenic yeasts exploit their capacity to adhere to abiotic surfaces such as plastic prostheses to gain access to the bloodstream and internal organs of patients (Kojic and Darouiche, 2004).”
- Yeasts in food and beverages (2006, background): “Epidemiological statistics suggest that many yeast infections in hospitalized patients originate from yeast contamination of catheters (Douglas 2003; Kojic and Daroviche 2004), and there is increasing concern that foods could be a significant 1 • The Commercial and Community Significance 7”
- Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. (2013, background): “One hypothesis is that the presence of the matrix restricts the penetration of drugs through the formation of a diffusion barrier (Kojic & Darouiche, 2004), and only the most superficial layers are in contact with lethal doses of antibiotics.”
- Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. (2012, background): “Catheters, like other medical devices, can serve as a substrate for Candida biofilm infection, which exhibits a drug-resistant phenotype [60, 61], necessitating biofilm extirpation for treatment success [62, 63].”
- Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. (2012, background): “…but it is generally accepted that the increased and widespread use of certain medical practices, such as immunosuppressive therapies, invasive surgical procedures and use of broad-spectrum antibiotics are significant (Samaranayake et al., 2002; Hagerty et al., 2003; Kojic & Darouiche, 2004).”